This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Nordic Boiscience A/s. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Emma Åhrman: Innovator in Pathological Cartilage Turnover Detection
Introduction
Emma Åhrman is a notable inventor based in Lomma, Sweden. She has made significant contributions to the field of medical diagnostics, particularly in the detection of pathological cartilage turnover. Her innovative work has the potential to enhance the understanding and treatment of cartilage-related diseases.
Latest Patents
Emma Åhrman holds a patent for a method titled "Determining pathological cartilage turnover." This invention relates to the detection of Cartilage Oligomeric Matrix Protein (COMP) neoepitopes, which are crucial for identifying pathological changes in cartilage. The methods described in her patent involve detecting these neoepitopes in body fluids and tissues. Additionally, her patent includes the development of antibodies against COMP neoepitopes, as well as fragments and peptides that can be used to generate such antibodies.
Career Highlights
Throughout her career, Emma has worked with prominent companies in the biotechnology sector, including Nordic Bioscience A/S. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Emma has collaborated with notable professionals such as Pilar Lorenzo and Patrik Önnerfjord. These partnerships have further enriched her research and development efforts in the area of cartilage turnover detection.
Conclusion
Emma Åhrman is a pioneering inventor whose work in detecting pathological cartilage turnover is paving the way for advancements in medical diagnostics. Her contributions are vital for improving the understanding of cartilage health and disease.